Date published: 2025-9-12

1-800-457-3801

SCBT Portrait Logo
Seach Input

PAPD4 Activators

PAPD4 Activators are a set of chemicals that facilitate the functional activity of PAPD4 through their influence on various biochemical signaling pathways. Forskolin, by increasing adenylate cyclase activity and thereby raising cAMP levels, indirectly supports the activity of PAPD4 through cAMP-dependent PKA, which can phosphorylate proteins and alter signaling pathways that PAPD4 is a part of. Genistein, as a tyrosine kinase inhibitor, reduces competitive phosphorylation events, potentially allowing for enhanced PAPD4 activity within those pathways. Sphingosine-1-phosphate and Thapsigargin both act on lipid and calcium signaling, respectively, with Sphingosine-1-phosphate activating its receptors and modulating downstream signaling that affects PAPD4 activity, and Thapsigargin raising intracellular calcium to activate calcium-dependent signaling pathways where PAPD4 operates. PMA's activation of PKC and the PI3K inhibitors LY294002 and Wortmannin can indirectly promote PAPD4's activity by shifting the balance of cellular signaling in its favor, as these molecules alter the phosphorylation landscape that PAPD4 is likely involved in.

The activity of PAPD4 is further assisted by compounds that target the MAPK signaling cascade. SB203580 and U0126 work by inhibiting p38 and MEK1/2, respectively, which might lead to a compensatory activation of pathways involving PAPD4, indirectly enhancing its functional role. The ionophore A23187 facilitates PAPD4's activity by elevating intracellular calcium levels and thus activating calcium-dependent signaling pathways crucial for PAPD4's role in the cell. Meanwhile, Staurosporine, by broadly inhibiting protein kinases, might lead to the selective activation of pathways involving PAPD4 by reducing the inhibition exerted by certain kinases on PAPD4-related processes. Lastly, Epigallocatechin gallate (EGCG) serves to enhance PAPD4 activity by inhibiting kinases that may negatively regulate pathways that PAPD4 is part of, thus providing a less antagonistic environment for PAPD4's functional operations.

SEE ALSO...

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

EGCG inhibits multiple kinases, potentially leading to an enhancement of signaling pathways in which PAPD4 is involved by reducing negative regulatory influences on these pathways.